StockData
NovaBridge Biosciences logo

NovaBridge Biosciences (NBP) stock

NBPNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 7, 2026Score 0/30
$0.82+0.03 (+3.89%)

Close on Nov 17, 2026Market cap $94.88MP/E –Yield –

NovaBridge Biosciences total assets

Total assets on the balance sheet at the end of each period.

NovaBridge Biosciences's total assets was CN¥2.61B at Dec 31, 2023. For fiscal 2023 it was CN¥2.61B, down 35.9% from the year before. The highest annual figure on record is CN¥6.33B in fiscal 2020.

Annual total assets

PeriodPeriod endValueChange
FY2023Dec 31, 2023CN¥2.61B-35.9%
FY2022Dec 31, 2022CN¥4.07B-27.3%
FY2021Dec 31, 2021CN¥5.60B-11.6%
FY2020Dec 31, 2020CN¥6.33B+264.5%
FY2019Dec 31, 2019CN¥1.74B-26.9%
FY2018Dec 31, 2018CN¥2.38B–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2023Dec 31, 2023CN¥2.61B-58.7%
Q4 FY2022Dec 31, 2022CN¥4.07B-5.2%
Q2 FY2022Jun 30, 2022CN¥4.99B+187.3%
Q4 FY2021Dec 31, 2021CN¥5.60B+135.7%
Q4 FY2020Dec 31, 2020CN¥6.33B–
Q3 FY2020Sep 30, 2020CN¥4.30B–
Q4 FY2019Dec 31, 2019CN¥1.74B–
Q4 FY2018Dec 31, 2018CN¥2.38B–

More NovaBridge Biosciences figures

See a number that looks wrong?